Prabhudas Lilladher reaffirms its "Buy" stance on Sun Pharmaceutical Industries Ltd. (SUNP), revising the target price to Rs.2,100 from Rs.1,885.

Prabhudas Lilladher has issued a BUY recommendation for Eris Lifesciences, setting a target price of Rs 1,420.

Morningstar has issued a HOLD recommendation on Merck & Co. Inc., maintaining a fair value estimate of $120, with the stock currently trading at $105.88.

KRChoksey has downgraded its stance on Laurus Labs to "ACCUMULATE" from "BUY," with a revised target price of Rs 489, implying a modest 5.4% upside from the current price of Rs 464.

Motilal Oswal has issued a BUY call on Piramal Pharma with a revised target price of Rs 310, indicating a 21% upside from its current market price of Rs 256.

Morningstar’s recent analysis suggests a "Buy" on Intellia Therapeutics, assigning a fair value of $85 per share, while the current trading price is significantly lower at $15.85.